BLEEDnFIRE Therapeutics
PrivateLast Round
Grant
May 27, 2026
Total Funding Raised
$170,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BLEEDnFIRE Therapeutics is a biotechnology company developing first-in-class RNA-based therapies for rare bleeding disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BLEEDnFIRE Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
BLEEDnFIRE Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 27, 2026 | ||||
| Grant | Nov 29, 2024 |
BLEEDnFIRE Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gebert Rüf Stiftung | Grant |
| Kickfund | Grant |
| Innosuisse | Grant |
| Venture Kick | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
Received funding from Kickfund, Gebert Rüf Stiftung, Innosuisse, and Venture Kick.
BLEEDnFIRE Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BLEEDnFIRE Therapeutics's valuation, stock price, and market status.